Vicarious Surgical (RBOT) Cash from Operations Growth (1y) (2021 - 2025)
Vicarious Surgical (RBOT) Cash from Operations Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | -12.60% |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.53% |
| Jun 30, 2025 | -22.78% |
| Mar 31, 2025 | 18.61% |
| Dec 31, 2024 | -3.68% |
| Sep 30, 2024 | 26.58% |
| Jun 30, 2024 | 26.93% |
| Mar 31, 2024 | 22.14% |
| Dec 31, 2023 | 38.24% |
| Sep 30, 2023 | -24.91% |
| Jun 30, 2023 | -6.22% |
| Mar 31, 2023 | -25.75% |
| Dec 31, 2022 | -88.75% |
| Sep 30, 2022 | -1.43% |
| Jun 30, 2022 | -146.34% |
| Mar 31, 2022 | -256.69% |
| Dec 31, 2021 | -2,182.47% |
| Sep 30, 2021 | -3,822.41% |